804-GB) inhibits Recombinant Human IGF-II (Catalog #
292-G2) induced proliferation in the MCF-7 human breast cancer cell line in a dose-dependent manner (orange line), as measured by Resazurin (Catalog #
AR002). Inhibition of Recombinant Human IGF-II (14 ng/mL) activity elicited by Recombinant Human IGFBP-4 (0.3 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human IGFBP-4 Monoclonal Antibody (Catalog # MAB8041R). The ND
50 is typically 20-80 µg/mL." class="big_lightbox">

804-GB) inhibits Recombinant Human IGF-II (Catalog #
292-G2) induced proliferation in the MCF-7 human breast cancer cell line in a dose-dependent manner (orange line), as measured by Resazurin (Catalog #
AR002). Inhibition of Recombinant Human IGF-II (14 ng/mL) activity elicited by Recombinant Human IGFBP-4 (0.3 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human IGFBP-4 Monoclonal Antibody (Catalog # MAB8041R). The ND
50 is typically 20-80 µg/mL." alt="Recombinant Human IGFBP-4 (Catalog #
804-GB) inhibits Recombinant Human IGF-II (Catalog #
292-G2) induced proliferation in the MCF-7 human breast cancer cell line in a dose-dependent manner (orange line), as measured by Resazurin (Catalog #
AR002). Inhibition of Recombinant Human IGF-II (14 ng/mL) activity elicited by Recombinant Human IGFBP-4 (0.3 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human IGFBP-4 Monoclonal Antibody (Catalog # MAB8041R). The ND
50 is typically 20-80 µg/mL." class="big_thumb" />